Answers are grounded in this paper and cite their sources.
The reactions of two diazabutadiene ligands, Ar-DAB [(ArNCH)2 , Ar = 2,6-Pri2C6H3] and But-DAB [(ButNCH)2] with either GaI or an AlI3/Al mixture have afforded the paramagnetic compounds, [{IGaII(But-DAB)}2], [I2GaIII(But-DAB)] and [I2AlIII(Ar-DAB)] which have been characterised by X-ray crystallography and EPR spectroscopy. In addition, the diamagnetic, ionic complex, [I2AlIII(Ar-DAB)]I, has been prepared and structurally characterised. The reduction of [I2GaIII(Ar-DAB)] with potassium metal in the presence of various Lewis bases has led to three structurally characterised compounds, [{(Et2O)KGaI(Ar-DAB)}2], [{(TMEDA)KGaI(Ar-DAB)}2] and [:GaI(Ar-DAB)]2[{K(18-crown-6)}2(μ-18-crown-6)], which contain the second example of an anionic gallium(I) carbene analogue. In addition, the former two compounds display Ga⋯Ga interactions in the solid state which are unprecedented for this complex type.
No takes yet. Share an insight, caveat, or question.
Baker et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: